What's new

Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised

Feb 20, 2025 - 13:18
 0
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Giles Kinnersley joins AMPECO as Business Development Director for the UK and Ir...

Next Article

India advises co-location of energy storage with solar PV

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0541/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025  0

Veterinary medicines European public assessment report (EPAR): Vectormune HVT-AIV, Avian influenza vaccine, Status: Opinion

Veterinary medicines European public assessment report ...

Feb 14, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Saxenda, liraglutide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0468/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0